Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.

MLA

Lim-Fat, Mary Jane, et al. “Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 30, no. 7, Apr. 2024, pp. 1327–37. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-23-3018.

APA

Lim-Fat, M. J., Iorgulescu, J. B., Rahman, R., Bhave, V., Muzikansky, A., Woodward, E., Whorral, S., Allen, M., Touat, M., Li, X., Xy, G., Patel, J., Gerstner, E. R., Kalpathy-Cramer, J., Youssef, G., Chukwueke, U., McFaline-Figueroa, J. R., Nayak, L., Lee, E. Q., … Wen, P. Y. (2024). Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 30(7), 1327–1337. https://doi.org/10.1158/1078-0432.CCR-23-3018

Chicago

Lim-Fat, Mary Jane, J Bryan Iorgulescu, Rifaquat Rahman, Varun Bhave, Alona Muzikansky, Eleanor Woodward, Sydney Whorral, et al. 2024. “Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 30 (7): 1327–37. doi:10.1158/1078-0432.CCR-23-3018.